Intramuscular versus Intravenous Therapy for Prehospital Status Epilepticus

In this trial, subjects in status epilepticus were given either intramuscular midazolam or intravenous lorazepam by paramedics before arrival in the ER. Seizures were controlled in more subjects with midazolam, and midazolam was at least as safe and effective as lorazepam. Early termination of prolo...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 366; no. 7; pp. 591 - 600
Main Authors Silbergleit, Robert, Durkalski, Valerie, Lowenstein, Daniel, Conwit, Robin, Pancioli, Arthur, Palesch, Yuko, Barsan, William
Format Journal Article
LanguageEnglish
Published Waltham, MA Massachusetts Medical Society 16.02.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In this trial, subjects in status epilepticus were given either intramuscular midazolam or intravenous lorazepam by paramedics before arrival in the ER. Seizures were controlled in more subjects with midazolam, and midazolam was at least as safe and effective as lorazepam. Early termination of prolonged epileptic seizures in response to intravenous administration of benzodiazepines by paramedics in the prehospital setting is associated with better patient outcomes. The randomized, controlled Prehospital Treatment of Status Epilepticus (PHTSE) trial (ClinicalTrials.gov number, NCT00004297) compared diazepam, lorazepam, and placebo given intravenously by paramedics to treat subjects with prolonged convulsive seizures. 1 The trial showed that both these benzodiazepines were an effective prehospital treatment for seizures, as compared with placebo. The proportion of subjects whose seizures were terminated at the time of arrival in the emergency department was 59.1% in the group receiving intravenous lorazepam, 42.6% in the . . .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ISSN:0028-4793
1533-4406
1533-4406
DOI:10.1056/NEJMoa1107494